Skip to content
Global Access Atlas

Market access pathways by country

Explore how an innovative medicine moves from approval to patient access.

Selected market

Vietnam

Separate Vietnamese registration, prescription wholesale-price publication, BHYT payment conditions, facility use and purchasing. First treatment depends on lawful supply and usable stock; claims settlement follows separately where applicable.

DAV / MOH / eligible registrant
Responsible manufacturer, commissioning party for medicines contract-manufactured in Vietnam or importer / MOH
Patient / provider / responsible payer
MOH / social insurance agency
Treating facility / responsible practitioners
9 decision nodes8 cited sources

For education only — not regulatory, pricing or legal advice.

About the content and how to use it